New Frontiers in 3D Cell Technologies
Bridging the gap from preclinical research to clinical trials
This year’s program includes talks by innovators in 3D cell technologies from Novo Nordisk, AstraZeneca, Takeda Pharmaceuticals, and MIT. Additional speakers will be selected from participants who submit presentation abstracts that illustrate how emerging technologies can be successfully applied in industry to improve drug discovery and safety testing. For more details on the program, visit the conference website.